afgen Says Obesity Drug Spurs Weight Loss in StudyBloomberg afgen Inc., a closely held developer of an experimental drug for obesity, said its therapy yielded weight loss of as much as 10 kilograms (22 pounds) in three months, an early look at study results showed. Patients taking the... http://farm4.staticflickr.com/3286/3013280274_1aa34cee4f.jpg
Check Out The Entire News Here
Saturday, June 22, 2013
Weight Loss: Zafgen Says Obesity Drug Spurs Weight Loss in Study - Bloomberg
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment